Humetrix demonstrates iBlueButton at UK expo

Editorial Staff | | Health Exec | Precision Medicine

Crossing into new markets, Calif.-based Humetrix showed off its mobile health information exchange app iBlueButton at the UK National Health Service Innovation Expo 2013 last week. The event, which took place on March 13 and 14 in London, was geared to European health IT professionals.

Humetrix joined EHR vendors Cerner and TPP to demonstrate data exchange on the mobile platform, according to its March 14 company press release. Humetrix showed how the iBlueButton consumer app can download a patient’s hospital discharge summary from a Cerner inpatient EMR and then share the record with the patient’s physician using mobile-to-mobile push technology.  Also, it showed how to download to a patient’s mobile device their health record as extracted from clinical software.

The iBlueButton technology, tailored to work with UK systems, is expected to be available to UK consumers this fall. The NHS faces a regulatory deadline of 2015 to make EHRs available and accessible to patients.

 

Editorial Staff

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?